iShares U.S. Medical Devices ETF Rating $60.23 -0.08 (-0.13%) As of 06/18/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares U.S. Medical Devices ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IHI Aggregate RatingModerate Buy 2.73Holdings in IHI have an aggregate rating of Moderate Buy based on 511 analyst ratings issued in the past year covering 47 companies (99.9% of the portfolio).IHI Aggregate Price Target$60.23High Prediction$60.23Average Prediction$60.23Low Prediction$60.23Holdings in IHI have an aggregate price target of $60.23 and a range of $60.23 to $60.23 covering 47 companies (99.9% of the portfolio).IHI Consensus Ratings of HoldingsStrong Buy2 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy24 Moderate Buy rating(s)Hold12 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Medical Devices ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 47 IHI Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings18.94%ABTAbbott Laboratories$132.35+0.1%4.9298 of 5 stars2.76$142.61 7.8%21Trending NewsDividend AnnouncementAnalyst Revision15.04%ISRGIntuitive Surgical$509.49-0.5%4.7721 of 5 stars2.70$588.95 15.6%20Positive News11.32%BSXBoston Scientific$101.36-0.4%4.5874 of 5 stars3.13$116.09 14.5%24Trending NewsAnalyst Revision5.04%IDXXIDEXX Laboratories$519.85-0.1%3.8179 of 5 stars2.78$546.00 5.0%9Positive News4.80%EWEdwards Lifesciences$73.94+0.9%4.5172 of 5 stars2.40$80.20 8.5%25Positive News4.56%SYKStryker$373.220.0%4.9079 of 5 stars2.79$427.30 14.5%19Positive News4.34%RMDResMed$250.87+0.3%4.1188 of 5 stars2.60$259.33 3.4%15Positive News4.19%MDTMedtronic$85.68-0.6%4.8997 of 5 stars2.67$97.87 14.2%18Positive NewsAnalyst Revision3.81%GEHCGE HealthCare Technologies$71.89+1.1%4.2269 of 5 stars2.83$88.27 22.8%123.81%DXCMDexCom$81.01-1.0%4.8355 of 5 stars2.95$98.50 21.6%22Insider Trade3.36%BDXBecton, Dickinson and Company$168.54-0.8%4.9517 of 5 stars2.36$219.22 30.1%11Positive News2.78%STESTERIS$236.15-0.4%4.8793 of 5 stars2.63$263.83 11.7%8Positive News2.49%PODDInsulet$301.79-0.9%4.4063 of 5 stars2.83$321.00 6.4%18Positive News2.20%ZBHZimmer Biomet$90.47+0.3%4.9321 of 5 stars2.29$111.53 23.3%21Positive NewsAnalyst Revision1.88%BAXBaxter International$29.83-0.3%4.4432 of 5 stars2.44$37.25 24.9%9Positive News1.70%HOLXHologic$63.97-0.3%4.7631 of 5 stars2.41$77.42 21.0%17Positive NewsShort Interest ↓1.14%PENPenumbra$256.99+0.4%4.6764 of 5 stars2.88$302.40 17.7%170.87%MASIMasimo$162.77+2.2%3.9733 of 5 stars2.83$191.60 17.7%60.81%GMEDGlobus Medical$57.40-1.3%4.7192 of 5 stars2.62$94.00 63.8%130.67%TFXTeleflex$117.73+0.2%4.6099 of 5 stars2.09$164.63 39.8%110.64%GKOSGlaukos$102.31+2.5%4.5179 of 5 stars2.75$134.67 31.6%12Positive News0.56%TMDXTransMedics Group$124.00-9.0%1.2845 of 5 stars2.80$127.33 2.7%10Analyst Forecast0.54%IRTCiRhythm Technologies$145.53+0.4%1.2508 of 5 stars2.90$138.60 -4.8%100.47%ITGRInteger$118.86-0.2%3.7221 of 5 stars3.00$145.00 22.0%9Positive News0.46%INSPInspire Medical Systems$129.95+2.1%4.7971 of 5 stars2.73$211.91 63.1%11Positive News0.40%PRCTPROCEPT BioRobotics$59.66+1.1%1.9322 of 5 stars2.86$90.00 50.9%7Gap Up0.39%NVSTEnvista$18.62+1.0%3.5832 of 5 stars2.33$20.23 8.7%15Positive News0.30%LIVNLivaNova$45.17+1.8%2.7868 of 5 stars3.00$59.29 31.3%80.24%QDELQuidelOrtho$28.33+1.1%4.598 of 5 stars2.43$44.33 56.5%7Positive News0.22%ENOVEnovis$30.69-0.6%2.9709 of 5 stars2.80$58.00 89.0%5Positive News0.21%CNMDCONMED$52.01-0.4%4.392 of 5 stars2.20$62.20 19.6%5Positive News0.20%LMATLeMaitre Vascular$81.69+0.8%2.7738 of 5 stars2.33$97.83 19.8%6Positive News0.20%NVCRNovoCure$16.80-3.6%4.2683 of 5 stars2.67$32.83 95.4%6Positive News0.19%ATRCAtriCure$31.61-3.0%3.6857 of 5 stars3.00$50.67 60.3%9Positive News0.17%TNDMTandem Diabetes Care$20.41+1.7%4.1456 of 5 stars2.40$33.43 63.8%15Positive News0.17%OMCLOmnicell$28.27-0.8%2.3091 of 5 stars2.57$44.83 58.6%7Positive News0.14%ATECAlphatec$10.89+0.4%4.4213 of 5 stars2.89$17.89 64.3%9Insider Trade0.13%AORTArtivion$29.66-0.4%2.5555 of 5 stars3.14$32.00 7.9%7Analyst ForecastInsider Trade0.10%IARTIntegra LifeSciences$11.91-2.0%4.4694 of 5 stars1.78$18.63 56.4%90.08%SIBNSiBone$16.68-2.7%3.8441 of 5 stars3.00$22.50 34.9%4Positive News0.05%OFIXOrthofix Medical$10.35-1.6%2.8283 of 5 stars2.75$23.33 125.4%4Short Interest ↑High Trading Volume0.05%AXGNAxoGen$9.29-2.5%2.7011 of 5 stars3.00$22.20 139.0%5Positive News0.05%BFLYButterfly Network$2.17-1.6%1.7728 of 5 stars3.00$4.00 84.8%20.05%SRDXSurmodics$29.14+0.3%3.3846 of 5 stars2.50$43.00 47.6%20.04%SENSSenseonics$0.51+1.2%1.8435 of 5 stars3.50$1.55 206.7%20.04%VREXVarex Imaging$7.67-1.3%4.5695 of 5 stars3.50$22.50 193.4%2Positive News0.03%TMCITreace Medical Concepts$5.46+0.4%2.0869 of 5 stars2.29$10.16 86.0%7 This page (NYSEARCA:IHI) was last updated on 6/20/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump Makes Major Crypto AnnouncementTrump's crypto revolution is now fully underway and now, we believe he’s about to deliver on his biggest promi...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Medical Devices ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Medical Devices ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.